Related Experiment Video

Updated: May 23, 2026

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy

Ning Sun1, Masayuki Yazawa, Jianwei Liu

  • 1Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Science Translational Medicine
|April 21, 2012
PubMed

Insights

Induced pluripotent stem cells from dilated cardiomyopathy patients create disease models. These models show DCM characteristics and improve with certain treatments, aiding drug screening.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Genetics

Background:

  • Dilated cardiomyopathy (DCM) is a common heart condition causing heart failure and requiring transplantation.
  • Induced pluripotent stem cells (iPSCs) offer a powerful tool for modeling genetic cardiovascular diseases.
  • Patient-derived iPSCs can create personalized cellular models for studying disease mechanisms.

Purpose of the Study:

  • To generate and characterize iPSC-derived cardiomyocytes from a DCM family with a cardiac troponin T mutation.
  • To investigate the cellular and functional phenotypes of DCM in these patient-derived cardiomyocytes.
  • To evaluate potential therapeutic strategies using these iPSC-based disease models.

Main Methods:

  • Generation of iPSCs from DCM patients and healthy family members.
  • Differentiation of iPSCs into cardiomyocytes.
  • Assessment of cellular function, calcium handling, and sarcomeric structure.
  • Pharmacological stimulation and genetic manipulation (Serca2a overexpression).

Main Results:

  • DCM iPSC-derived cardiomyocytes displayed impaired calcium regulation, reduced contractility, and abnormal sarcomeric organization.
  • Cells showed heightened sensitivity to cellular stress, with reduced beating and contraction.
  • Treatment with beta-blockers or Serca2a overexpression ameliorated functional deficits.

Conclusions:

  • iPSC-derived cardiomyocytes from DCM patients effectively model key aspects of the disease.
  • This platform facilitates the study of DCM pathogenesis and the screening of potential therapeutics.
  • The findings highlight the potential of iPSC technology in personalized cardiovascular medicine.

More Related Videos

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization08:06

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.08:37

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.